Maternal nitric oxide supplementation decreases cord blood S100B in intrauterine growth-retarded fetuses.

Intrauterine growth retardation (IUGR) is thought to reflect suppression of genetic growth potential by decreased supplies of oxygen and substrate (1). NO supplementation may be useful in IUGR to increase uteroplacental circulation (2)(3)(4)(5). The use of biochemical markers to assess the extent of brain distress associated with NO treatment could be appropriate. S100B is an acidic calcium-binding protein of the EF-hand family concentrated in the nervous system (6). The appearance of S100B in biological fluids is an indicator of brain distress in both infants and adults (7)(8)(9)(10). Recently, blood S100B concentrations in the perinatal period have been shown to correlate with brain maturation and damage (11)(12)(13)(14). We investigated the effect of maternal NO supplementation on brain distress in IUGR fetuses as assessed by cord blood S100B. We selected 51 pregnant women (gestational age, 27–35 weeks) with IUGR fetuses and impaired uteroplacental blood flow. Exclusion criteria included multiple pregnancies, gestational and type 1 diabetes, maternal infections and fever, fetal malformations and chromosomal abnormalities, metabolic diseases, and maternal diseases of the central nervous system. Patients were assigned, by use of computer-generated random numbers, to receive either placebo (n = 25) or transdermal glyceryl trinitrate (Nitroderm TTS; Ciba-Geigy) at a dose of 5 mg/16 h daily until delivery (n = 26). Placebo and glyceryl trinitrate patches were indistinguishable and were numbered and contained in identical envelopes so that patients did not know the group to which they were recruited. Similarly, neither the physicians nor the investigators who analyzed the samples knew which patients were treated with placebo and which with glyceryl trinitrate patches. The local ethics committee approved the study, and written informed consent was obtained from all participants. Two patients in the glyceryl …

[1]  F. Michetti,et al.  Increased urinary S100B protein as an early indicator of intraventricular hemorrhage in preterm infants: correlation with the grade of hemorrhage. , 2001, Clinical chemistry.

[2]  F. Michetti,et al.  S100b protein concentrations in urine are correlated with gestational age in healthy preterm and term newborns. , 2001, Clinical chemistry.

[3]  F. Michetti,et al.  S100B protein concentrations in cord blood: correlations with gestational age in term and preterm deliveries. , 2000, Clinical chemistry.

[4]  K. Haglid,et al.  Elevated S100 blood level as an early indicator of intraventricular hemorrhage in preterm infants Correlation with cerebral Doppler velocimetry , 1999, Journal of the Neurological Sciences.

[5]  F. Facchinetti,et al.  L-Arginine Infusion Reduces Blood Pressure in Preeclamptic Women Through Nitric Oxide Release , 1999, The Journal of the Society for Gynecologic Investigation: JSGI.

[6]  K. Teramo,et al.  Effects of transdermal nitroglycerin on impedance to flow in the uterine, umbilical, and fetal middle cerebral arteries in pregnancies complicated by preeclampsia and intrauterine growth retardation. , 1998, American journal of obstetrics and gynecology.

[7]  F. Michetti,et al.  S100 blood concentrations in children subjected to cardiopulmonary by-pass. , 1998, Clinical chemistry.

[8]  E. Cosmi,et al.  Amniotic fluid nitric oxide and uteroplacental blood flow in pregnancy complicated by intrauterine growth retardation , 1997, British journal of obstetrics and gynaecology.

[9]  G. Mason,et al.  Differentiation of growth retarded from normally grown fetuses and prediction of intrauterine growth retardation using Doppler ultrasound , 1996, British journal of obstetrics and gynaecology.

[10]  D. Zimmer,et al.  The S100 protein family: History, function, and expression , 1995, Brain Research Bulletin.

[11]  C. Grunewald,et al.  Effects of Nitroglycerin on the Uterine and Umbilical Circulation in Severe Preeclampsia , 1995, Obstetrics and gynecology.

[12]  I. Greer,et al.  Nitric oxide concentrations are increased in the fetoplacental circulation in preeclampsia. , 1995, American journal of obstetrics and gynecology.

[13]  S. Bewley,et al.  Doppler investigation of uteroplacental blood flow resistance in the second trimester: a screening study for pre‐eclampsia and intrauterine growth retardation , 1991, British journal of obstetrics and gynaecology.

[14]  H. Hårdemark,et al.  S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. , 1987, Stroke.

[15]  D. Marshak,et al.  Characterization of Human Brain S100 Protein Fraction: Amino Acid Sequence of S100β , 1985, Journal of neurochemistry.

[16]  K. Haglid,et al.  Purification, characterization and ion binding properties of human brain S100b protein. , 1984, Biochimica et biophysica acta.

[17]  F. Michetti,et al.  The S-100 antigen in cerebrospinal fluid as a possible index of cell injury in the nervous system , 1980, Journal of the Neurological Sciences.

[18]  F. Michetti,et al.  The nervous system-specific S-100 antigen in cerebrospinal fluid of multiple sclerosis patients , 1979, Neuroscience Letters.

[19]  S. Campbell,et al.  ULTRASOUND MEASUREMENT OF THE FETAL HEAD TO ABDOMEN CIRCUMFERENCE RATIO IN THE ASSESSMENT OF GROWTH RETARDATION , 1977, British Journal of Obstetrics and Gynaecology.